FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

AID - 1056 - Malaria Vaccine Development Program Scientific Advisory Committee - Agency Authority

GENERAL INFORMATION

Committee Name	Malaria Vaccine Development Program Scientific Advisory Committee	Agency Name	Agency for International Development
Fiscal Year	2025	Committee Number	1056
Original Establishment Date	11/27/1989	Committee Status	Terminated
Actual Termination Date	2/25/2025	Committee URL
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	13
Terminated This FY	Yes	Designated Fed Officer Position Title*	DFO
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	7/29/2024	Designated Federal Officer First Name*	Susan
Date Of Renewal Charter	7/29/2026	Designated Federal Officer Middle Name
Projected Termination Date	2/25/2025	Designated Federal Officer Last Name*	Youll
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority		Designated Federal Officer Phone*	202-916-2108
Establishment Authority*	Agency Authority	Designated Federal Officer Fax*
Specific Establishment Authority*	Action Memorandum	Designated Federal Officer Email*	syoull@usaid.gov
Effective Date Of Authority*	8/6/1997
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	No
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The committee reviews malaria vaccine development progress and plans on a semi-annual or annual basis. Following an extensive review of data and progress presented by MVDP staff or collaborators, the committee deliberates and makes recommendations on specific approaches to malaria vaccine development, which are then incorporated into the plans as appropriate.
How is membership balanced?*	The committee includes members with experience in industry and academia, and with expertise in vaccine development, malariology, immunology, molecular biology, and clinical evaluation of vaccines. Both broad and specific technical advice is therefore available.
How frequent & relevant are cmte mtgs?*	The meetings are held semi-annually or annually to provide the necessary oversight to ensure the continuing appropriate conduct of the program. The MVDP staff sets the agenda in consultation with the committee chairman and members and invites collaborators to present recent work. As such, the committee is presented with the most relevant and up-to-date information on which to make their recommendations.
Why advice can't be obtained elsewhere?*	The committee is necessary to provide the requisite transparency and credibility to the process. Also, the MVDP staff value the committee's broad experience in all fields of malaria vaccine development and rely on the committee members for assistance in planning program direction.
Why close or partially close meetings?	Meetings may be closed or partially closed to protect information that would disclose confidential trade secrets or commercial property such as patentable material.
Recommendation Remarks

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	No	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment		Number Of Grants Recommended	0
Cost Savings*	None	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment		Grants Review Comment
Number Of Recommendations*	0	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment		Access Agency Website
% of Recs Fully Implemented*		Access Committee Website
% of Recs Fully Implemented Comment		Access GSA FACA Website
% of Recs Partially Implemented*		Access Publications
% of Recs Partially Implemented Comment		Access Other
Agency Feedback*		Access Comment
Agency Feedback Comment*		Narrative Description*

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	2/19/2025 10:11 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Medicine Diseases Research Research and Development Science and Technology Innovation Science and Technology

Custom Links

Committee Level Reports